Because proliferation of FOXP3+ Tregs can be induced by DNA methyltransferase inhibitor such as AZA and EGCG [17, 28–30], the epigenetic regulation of the FOXP3 gene via DNMT3b shows potential therapeutic targets for atherosclerosis. This evidence concerns the gene FOXP3 and atherosclerosis.